Course summary

The MSc in Cancer Therapies is unique in the UK. It's a multifaceted course and the only one which combines a focus on cancer biology, drug discovery, formulation and delivery with radiation biology. You'll also get an understanding of the practical, ethical and economic implications of personalised cancer therapy. The degree is for graduates seeking experience in the range of topics essential to the understanding and development of cancer therapies.  You'll be taught in the Strathclyde Institute of Pharmacy & Biomedical Sciences, recognised as one of the leading departments of its kind in the UK. The Institute has major facilities for radiobiology and radiopharmaceutical research. It also hosts the Cancer Research UK Drug Formulation Unit - the only one of its kind in the UK. You'll therefore be taught by researchers working at the forefront of basic, translational, industrial and clinical cancer research in the biomedical and physical sciences arenas. The course has been developed to produce world-class graduates with the skills to contribute to the global drive in advancing cancer treatment through research, teaching, industry and public sector employment. Studying with us will provide you with the skills to assess, analyse, critically appraise and evaluate current and emerging anti-cancer therapies and the drug discovery cascade - from target evaluation and engagement to clinical trials. The course will also provide you with the specialist research training and a breadth of skills needed for your future career. The masters degree has been designed in response to a growing demand from academia, industry and health care providers for a course which focuses on current and emerging cancer therapies, in a format which covers essential multidisciplinary aspects of the topic.